… severe acute respiratory syndrome coronavirus-2 (SARS-… -2-induced coronavirus disease-19
(COVID-19) has become one … -2 infection and COVID-19 development and progression to …

… The most commonly reported conditions in allergic patients diagnosed with COVID-19 were
asthma and allergic rhinitis (Figure 1, Q7). About 80.4% of HCPs indicated being affected …

… allergy clinics, specialized centres and practices with practical recommendations on
measures for daily practice and optimal care for allergic patients during the current COVID-19 …

… , Sanofi Genzyme, Zeller, and the European Institute of Technology (EIT); has received
travel support from the European Academy of Allergy and Clinical Immunology (EAACI) and …

… strain of human coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
was identified as the cause of the Coronavirus disease 2019 (COVID-19) declared to …

… Further to the approval of the Coronavirus disease 2019 (COVID-19) vaccine BNT162b2, …
With the current information, the European Academy of Allergy and Clinical Immunology (…

… As in many fields of medical care, the coronavirus disease 2019 (COVID-19) resulted in an
increased uncertainty regarding the safety of allergen immunotherapy (AIT). Therefore, the …

… COVID-19 pandemic, the treatment of patients with allergic … risk of a severe COVID-19 course
in allergic patients. Many … with allergic and atopy-associated diseases during the COVID-19 …

… This position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
agrees with these recommendations and clarifies that there is no contraindication to …

… of an infectious disease defined as “Coronavirus disease 2019 (COVID-19)”. The COVID-19
pandemic is currently spreading around the globe. COVID-19 is caused by a novel strain of …